Key Insights

Highlights

Treatment Research

1 treatments under study, led by A Single Oral 5 Mg Of Duterium Labeled Methamphetamine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01529892Phase 4WithdrawnPrimary

The Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine

Showing all 1 trials

Research Network

Common Treatments

  • A Single Oral 5 Mg Of Duterium Labeled Methamphetamine1

Active Sponsors

  • California Pacific Medical Center Research Institute1
  • Children's Mercy Hospital Kansas City1

Top Investigators

Activity Timeline